Reduced Inflammatory Activity in Atherosclerotic Plaques after Peptide Receptor-Targeted Radionuclide Therapy Detected by [68Ga]Ga-DOTATOC PET

被引:0
|
作者
Kosmala, Aleksander
Weich, Alexander
Serfling, Sebastian
Schlotelburg, Wiebke
Michalski, Kerstin
Meining, Alexander
Higuchi, Takahiro
Buck, Andreas
Werner, Rudolf
Hartrampf, Philipp
机构
关键词
D O I
暂无
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
242046
引用
收藏
页数:3
相关论文
共 50 条
  • [21] Preliminary results of a Peptide Receptor Radionuclide-Therapy (PRRT) trial: prognostic role of baseline 68Ga-DOTATOC PET/CT and tumour dosimetry
    Filice, A.
    Fioroni, F.
    Grassi, E.
    Finocchiaro, D.
    Fraternali, A.
    Coruzzi, C.
    Asti, M.
    Giulia, B.
    Frasoldati, A.
    Versari, A.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2018, 45 : S588 - S589
  • [22] Evaluation of the radiotracer [68Ga]pentixafor targeting the CXCR4 receptor with PET-MRI in a rabbit model of atherosclerotic plaques
    Hyafil, F.
    Laitinen, I.
    Schottelius, M.
    Mohring, M.
    Poschenrieder, A.
    Brandl, J.
    Baumgartner, C.
    Pelisek, J.
    Nekolla, S.
    Wester, H.
    Schwaiger, M.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2015, 42 : S194 - S195
  • [23] Gastroenteropancreatic Neuroendocrine Tumors: Standardizing Therapy Monitoring with 68Ga-DOTATOC PET/CT Using the Example of Somatostatin Receptor Radionuclide Therapy
    Luboldt, Wolfgang
    Hartmann, Holger
    Wiedemann, Baerbel
    Zoephel, Klaus
    Luboldt, Hans-Joachim
    MOLECULAR IMAGING, 2010, 9 (06) : 351 - 358
  • [24] The Additional Value of Somatostatin Receptor Positron Emission Computed Tomography ([68Ga]Ga-DOTATOC PET/CT) Compared with Magnetic Resonance Imaging of the Head and Neck Region in Paraganglioma Patients: A Pilot Study
    de Bresser, Carolijn J. M.
    Petri, Bart-Jeroen
    Braat, Arthur J. A. T.
    de Keizer, Bart
    van Treijen, Mark J. C.
    Dankbaar, Jan Willem
    Pameijer, Frank A.
    Kok, Marius G. J.
    de Ridder, Mischa
    van Nesselrooij, Bernadette P. M.
    de Bree, Remco
    de Borst, Gert J.
    Rijken, Johannes A.
    CANCERS, 2024, 16 (05)
  • [25] Organ-specific response to [177Lu]DOTATATE peptide receptor radionuclide therapy (PRRT) assessed by sequential [68Ga]DOTATOC PET/CT in patients with metastatic small intestine neuroendocrine tumors
    Bessac, Darejan Mamulashvili
    Baltzinger, Philippe
    Poterszman, Nathan
    Van, Floriane Pham
    Collen, Cedric
    Malouf, Gabriel G.
    Ouvrard, Eric
    Kaseb, Ashjan
    Porot, Clemence
    Ben Abdelghani, Meher
    Addeo, Pietro
    Mertz, Luc
    Goichot, Bernard
    Imperiale, Alessio
    ENDOCRINE, 2025, 87 (03) : 1333 - 1341
  • [26] Peptide receptor radionuclide therapy with Y-90 DOTATOC and Lu-177 DOTATATE in patients with progressive meningioma and prognostic value of pretherapeutic Ga-68 DOTATOC/-TATE PET/CT
    Ilhan, Harun
    Seystahl, Katharina
    Veit, Stoecklein
    Schueller, Ulrich
    Rushing, Elisabeth
    Nicolas, Guillaume
    Schaefer, Niklaus
    Pangalu, Athina
    Lehner, Sebastian
    Bartenstein, Peter
    Michael, Weller
    Tonn, Joerg
    Sommerauer, Michael
    Albert, Nathalie
    JOURNAL OF NUCLEAR MEDICINE, 2016, 57
  • [27] 68Ga-DOTATATE PET/CT parameters predict response to peptide receptor radionuclide therapy in neuroendocrine tumours
    Sharma, Rohini
    Wang, Wai Meng
    Yusuf, Siraj
    Evans, Joanne
    Ramaswami, Ramya
    Wernig, Florian
    Frilling, Andrea
    Mauri, Francesco
    Al-Nahhas, Adil
    Aboagye, Eric O.
    Barwick, Tara D.
    RADIOTHERAPY AND ONCOLOGY, 2019, 141 : 108 - 115
  • [28] Preclinical Evaluation of 68Ga/177Lu labeled novel FAP-targeted peptide for tumor radionuclide imaging and therapy
    Wang, Weichen
    Wang, Rang
    Huang, MingXing
    Tian, Rong
    JOURNAL OF NUCLEAR MEDICINE, 2024, 65
  • [29] The role of 68Ga-DOTATATE PET/CT imaging in the decision of Peptide Receptor Radionuclide Therapy (PRRT) administration
    Skoura, E.
    Michopoulou, S.
    AlMukhalid, O. M.
    Panagiotidis, E.
    Al Harbi, M.
    Kayani, I.
    Syed, R.
    Ell, P. J.
    Caplin, M. E.
    Bomanji, J.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2015, 42 : S293 - S294
  • [30] Peptide receptor radionuclide therapy of neuroendocrine tumors with 90Y-DOTATOC: Is treatment response predictable by pre-therapeutic uptake of 68Ga-DOTATOC?
    Oeksuez, M. Oe.
    Winter, L.
    Pfannenberg, C.
    Reischl, G.
    Muessig, K.
    Bares, R.
    Dittmann, H.
    DIAGNOSTIC AND INTERVENTIONAL IMAGING, 2014, 95 (03) : 289 - 300